BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 8, 2005
View Archived Issues
ViroPharma Prices $150M Offer To Add To Capital, Pay Off Debt
ViroPharma Inc. is raising $150.7 million through a public offering to support business development activities and general corporate purposes, as well as to pay off a portion of the company's debt. (BioWorld Today)
Read More
Antigenics Trims Work Force, Awaiting Results Of Phase III
Read More
Gene Therapy Firm Celladon Secures $30M Commitment
Read More
New MDD Report: Overview Of Cardiovascular Tech Sector
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More